HLVX · Categories · Form 4

HLVX - SEC Form 4 insider transactions

HilleVax Inc. (HLVX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for HLVX

• 257d
  SEC Form 4 filed by Large owner Takeda Pharmaceutical Co Ltd

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  SEC Form 4 filed by Large owner Frazier Life Sciences X, L.P.

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Cocero Nanette closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Hilleman Jeryl L closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Dubin Gary closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Chu Shelley closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  President and CEO Hershberg Robert closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Gerberding Julie L. closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Chief Financial Officer Maltbie Shane closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Sepulveda Jaime closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 259d
  Director Kohli Aditya closing all direct ownership in the company (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Heron Patrick J was granted 17,199 shares (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Kohli Aditya was granted 17,199 shares, increasing direct ownership by 3% to 698,171 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Chu Shelley was granted 17,199 shares (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Sepulveda Jaime was granted 17,199 shares, increasing direct ownership by 41% to 59,224 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Cocero Nanette was granted 17,199 shares (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Gerberding Julie L. was granted 17,199 shares, increasing direct ownership by 41% to 59,224 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Dubin Gary was granted 17,199 shares (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 343d
  Director Hilleman Jeryl L was granted 17,199 shares, increasing direct ownership by 41% to 59,224 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 399d
  SEC Form 4 filed by Director Gerberding Julie L.

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 399d
  SEC Form 4 filed by Director Chu Shelley

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 399d
  SEC Form 4 filed by Director Hilleman Jeryl L

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 399d
  SEC Form 4 filed by Director Cocero Nanette

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 399d
  SEC Form 4 filed by Director Sepulveda Jaime

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 399d
  SEC Form 4 filed by Director Heron Patrick J

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 476d
  Chief Financial Officer Maltbie Shane sold $15,117 worth of shares (8,291 units at $1.82), decreasing direct ownership by 9% to 79,887 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 476d
  Officer Hershberg Robert sold $48,661 worth of shares (26,535 units at $1.83), decreasing direct ownership by 2% to 1,101,498 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 733d
  SEC Form 4 filed by Frazier Life Sciences X, L.P. (Amendment)

  4/A - HilleVax, Inc. (0001888012) (Issuer)
• 742d
  Kohli Aditya sold $266,291 worth of shares (18,000 units at $14.79), decreasing direct ownership by 2% to 764,878 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 761d
  Kohli Aditya sold $96,770 worth of shares (6,898 units at $14.03), decreasing direct ownership by 0.87% to 782,878 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 789d
  Kohli Aditya sold $264,467 worth of shares (18,000 units at $14.69), decreasing direct ownership by 2% to 789,776 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 805d
  Kohli Aditya sold $985,536,428 worth of shares (18,000 units at $54,752.02), decreasing direct ownership by 2% to 807,776 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 817d
  Kohli Aditya sold $335,872 worth of shares (18,000 units at $18.66), decreasing direct ownership by 2% to 825,776 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 832d
  Kohli Aditya sold $269,078 worth of shares (18,000 units at $14.95), decreasing direct ownership by 2% to 843,776 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 840d
  Kohli Aditya sold $91,921 worth of shares (6,000 units at $15.32), decreasing direct ownership by 0.69% to 861,776 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 842d
  Kohli Aditya sold $132,383 worth of shares (8,866 units at $14.93) and was granted 54,898 shares, increasing direct ownership by 6% to 867,776 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 842d
  Maltbie Shane sold $53,395 worth of shares (3,576 units at $14.93) and was granted 47,522 shares, increasing direct ownership by 99% to 88,178 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 842d
  Hershberg Robert sold $173,161 worth of shares (11,597 units at $14.93) and was granted 174,202 shares, increasing direct ownership by 17% to 1,128,033 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 842d
  Borkowski Astrid sold $58,726 worth of shares (3,933 units at $14.93) and was granted 53,632 shares, increasing direct ownership by 30% to 214,892 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 852d
  SEC Form 4 filed by Mcloughlin Sean

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 898d
  Borkowski Astrid sold $155,000 worth of shares (10,000 units at $15.50), decreasing direct ownership by 6% to 165,193 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 911d
  Borkowski Astrid sold $287,000 worth of shares (20,000 units at $14.35), decreasing direct ownership by 10% to 175,193 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 926d
  Borkowski Astrid sold $140,000 worth of shares (10,000 units at $14.00), decreasing direct ownership by 5% to 195,193 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 933d
  Borkowski Astrid sold $65,000 worth of shares (5,000 units at $13.00), decreasing direct ownership by 2% to 205,193 units (SEC Form 4)

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1076d
  SEC Form 4 filed by Borkowski Astrid

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1090d
  SEC Form 4 filed by Chu Shelley

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1090d
  SEC Form 4 filed by Cocero Nanette

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1090d
  SEC Form 4 filed by Gerberding Julie L.

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1090d
  SEC Form 4 filed by Sepulveda Jaime

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1090d
  SEC Form 4 filed by Hilleman Jeryl L

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1090d
  SEC Form 4 filed by Heron Patrick J

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1120d
  SEC Form 4 filed by Cocero Nanette

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1216d
  SEC Form 4: Borkowski Astrid was granted 51,333 shares, increasing direct ownership by 30% to 219,774 units

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1216d
  SEC Form 4: Kohli Aditya was granted 85,466 shares, increasing direct ownership by 12% to 821,744 units

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1216d
  SEC Form 4: Hershberg Robert was granted 187,966 shares, increasing direct ownership by 24% to 965,428 units

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1216d
  SEC Form 4: Maltbie Shane was granted 43,333 shares, increasing direct ownership by 4,820% to 44,232 units

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1280d
  SEC Form 4: Takeda Pharmaceutical Co Ltd converted options into 5,883,500 shares

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1380d
  SEC Form 4 filed by Gerberding Julie L.

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1380d
  SEC Form 4 filed by Hilleman Jeryl L

  4 - HilleVax, Inc. (0001888012) (Issuer)
• 1380d
  SEC Form 4 filed by Chu Shelley

  4 - HilleVax, Inc. (0001888012) (Issuer)

Other HLVX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends